Cedars-Sinai Names New Radiation Oncology Chair
Katelyn M. Atkins, MD, PhD, Interim Chair Since 2025, Will Advance Radiotherapy Innovations and Oversee Enterprise Expansion
Cedars-Sinai has named Katelyn M. Atkins, MD, PhD, as chair of the Department of Radiation Oncology and the Ronald H. Bloom Family Chair in Cancer Therapeutics.
Atkins, interim chair of the department since December 2025, is an authority on thoracic and gastrointestinal cancers and plays a leading role in cardio-oncology research at Cedars-Sinai. She is overseeing a multiyear radiation oncology renovation to enhance patient experience and clinical outcomes.
“The future of radiation oncology is innovation,” Atkins said. “We will continue to drive technical and academic advances in our field, including the use of AI to better predict treatment response and side effects, and optimize outcomes for our patients.”
Atkins focuses on the intersection of cancer, cardiovascular disease and cancer treatment-related cardiac toxicities. She leads multiple cardio-oncology investigator-initiated clinical trials focused on understanding and measuring cardiovascular risk before and during treatment and over time.
She said that current radiation oncology innovations at Cedars-Sinai include the use of advanced imaging to optimize individual radiation doses to tumors and minimize exposure to healthy tissues. Radiotherapy can be a meaningful part of cancer care at multiple junctures, from curative-intent therapy to improving the quality of life for patients with advanced disease by relieving pain, bleeding and other symptoms, Atkins said.
“Our cancer care will be strengthened by Dr. Atkins’ clinical and operational leadership, her dedication to clinical excellence, and her vision for innovation and interdisciplinary research across the Cedars-Sinai enterprise,” said Ravi Thadhani, MD, MPH, executive vice president, chief physician executive and dean of the Medical Faculty.
Atkins joined the Cedars-Sinai faculty in 2019 and served as medical director of the Department of Radiation Oncology and radiation oncology director of Multidisciplinary Cancer Programs and Integration. She holds a joint appointment in the Department of Cardiology in the Smidt Heart Institute at Cedars-Sinai.
Cedars-Sinai leaders said she brings high energy and enthusiasm to her research and clinical responsibilities.
“Dr. Atkins is working to safely intertwine new and exciting therapies like immunotherapy and targeted agents with radiation in an aging population with significant cardiovascular disease,” said Bryan Croft, executive vice president and chief operating officer of Cedars-Sinai Medical Center. “She strives to optimize the health of increasing numbers of cancer survivors.”
Atkins has authored more than 90 peer-reviewed publications, including those in JAMA Oncology, the Journal of the American College of Cardiology, Circulation and Annals of Oncology. She is an associate editor of the International Journal of Radiation Oncology - Biology - Physics, a premier radiation oncology journal. She also serves on several external consensus guideline panels, including NRG Oncology and the United Nations Scientific Committee on the Effects of Atomic Radiation.
Atkins received her MD and PhD in cell and developmental biology from Oregon Health & Science University and completed her residency and served as chief resident at the Harvard Radiation Oncology Program. She trained at Massachusetts General Hospital, Brigham and Women’s Hospital, Dana-Farber Cancer Institute, Beth Israel Deaconess Medical Center and Boston Children’s Hospital.
Cedars-Sinai Health Sciences University is advancing groundbreaking research and educating future leaders in medicine, biomedical sciences and allied health sciences. Learn more about the university.